To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:9 Issue:9 Number:16 ISSN#:2564-2537
RCT
ACE Report #12324
Ace Report Cover Hand & Wrist

Corticosteroid Injection Addition to Casting is Superior to Casting Alone for De Quervain's Disease


How to Cite

OrthoEvidence. Corticosteroid Injection Addition to Casting is Superior to Casting Alone for De Quervain's Disease. ACE Report. 2020;9(9):16. Available from: https://myorthoevidence.com/AceReport/Report/12324

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Methylprednisolone acetate injection with casting versus casting alone for the treatment of De-Quervain's Tenosynovitis: a randomized controlled trial.

J Pak Med Assoc. 2020 Aug;70(8):1314-1318.

Contributing Authors:
M Akhtar S Faraz Ul Hassan Shah Gillani RD Nadeem M Tasneem

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and seventy-four patients with De Quervain's tenosynovitis were randomized to receive a thumb Spica cast and a corticosteroid injection (1mL of 10 mg) of triamcinolone acetonide and (1mL) lidocaine, or a thumb Spica cast alone to evaluate improvement in pain and function. The primary outcomes of interest included pain on a Visual Analog Scale (VAS) and the Quick Disability of the Arm, ...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.